AgingPhase 1PACENCT02203656
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
A Phase 1 study testing Nutritional Supplement, In-home exercise and Testosterone in people with Aging, run by The University of Texas Medical Branch, Galveston at 2 sites in United States.
Trial summary
The purpose of this study is to test the feasibility of interventions to accelerate recovery of muscle mass and function in older adults following acute hospitalization. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Aging
- What is being tested?
- Nutritional Supplement, In-home exercise and Testosterone
- Type of treatment
- Injection or infusion, Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 113 participants
- Where
- 2 sitesUnited States
- Study dates
- Oct 2013to Dec 2017
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Admitted to the University of Texas Medical Branch (UTMB) ACE unit with an admitting diagnosis of congestive heart failure, respiratory infection, kidney/urinary tract infection, or metabolic disorder; or other condition that will allow a subject to participate in the study after patient review
- Aged 65 years or older
- Self-reported ability (with or without the aid of an assistive device) to walk across a small room two weeks prior to hospitalization
- Lives within 30 miles of UTMB
- Can stand without assistance at the time of pretesting
- Presents no medical contraindication to wearing a loose fitting velcro strap for the accelerometer on one ankle
- Score ≥26 on the 30-item Mini Mental State Examination or alert and oriented X3 by physician on H\&P
- Is discharged "to home" at ACE unit discharge.
Who cannot join
- Nursing home resident or hospice patient
- Uncontrolled blood pressure (systolic >150, or diastolic > 100)
- History of stroke with motor disability
- Glomerular filtration rate (GFR) <30 mL/min/1.73m2 or evidence of kidney disease or failure
- Liver disease ( aspartate aminotransferase (AST) /Alanine transaminase (ALT) 2 times above the normal limit, hyperbilirubinemia)
- Recent (within 3 months) treatment with anabolic steroids
Show all 14Show fewer
- Any other condition or event considered exclusionary by the PI and faculty physician
- Planned or elective hospitalization within 30 days of discharge
- Additional Exclusion Criteria for Subjects Randomized to the Testosterone Group
- Breast or prostate cancer
- Palpable prostate nodule or induration or prostate specific antigen (PSA) ≥ 4 ng/ml
- PSA ≥ 3 ng/ml in men at high risk of prostate cancer, such as African Americans or men with first-degree relatives with prostate cancer
- Hematocrit ≥ 50%
- Decompensated heart failure as determined by a physician
Trial locations and contacts
2 sites in 1 country.
United States2 sites
UTMB Acute Care for Elders Unit
Galveston, Texas, 77550
Jennie Sealy Hospital
Galveston, Texas, 77555
About this study
Official title: Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
The purpose of this study is to test the feasibility of interventions to accelerate recovery of muscle mass and function in older adults following acute hospitalization.
Read the detailed description
The purpose of this study is to test the feasibility of interventions to accelerate recovery of muscle mass and function in older adults following acute hospitalization
- Conditions
- Aging
- Being tested
- Placebo, Nutritional Supplement, In-home exercise, Testosterone
- Keywords
- intervention studies, nutrition, exercise, testosterone, patient readmission
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PlaceboDrug
Also called Control
placebo supplement
Nutritional SupplementDietary supplement
protein supplement
In-home exerciseBehavioural
In-home exercise program
TestosteroneDrug
Also called Testosterone enanthate
Testosterone injection
| Study group | Role | What they receive |
|---|---|---|
| Placebo Supplement | Placebo comparator | Daily placebo supplement for 30 days after discharge. Receives: Drug: Placebo |
| Nutritional Supplement | Experimental | Daily nutritional supplement for 30 days after discharge. Receives: Dietary Supplement: Nutritional Supplement |
| In-home exercise + placebo | Experimental | in-home exercise 3 times a week and daily placebo supplement for 30 days after discharge. Receives: Drug: Placebo; Behavioral: In-home exercise |
| In-home exercise + nutrition | Experimental | in-home exercise 3 times a week and daily nutritional supplement for 30 days after discharge. Receives: Dietary Supplement: Nutritional Supplement; Behavioral: In-home exercise |
| Testosterone | Experimental | Single testosterone injection within 24 hours of hospital discharge. Receives: Drug: Testosterone |
What is being measured
The primary outcome is the main question the study is designed to answer.
Short Physical Performance Battery- Gait, Balance, Chair Rise changes in functional measure score
Changes in SPPB score
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
Secondary outcomes (7)
Body Composition
Body composition will be measured using a bioimpedance scale. Changes in weight and % body fat will be calculated over the duration of the intervention.
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
Hand grip strength (kg)
Changes in hand grip will be calculated over duration of study.
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
ADLS, IADLS
Changes in Instrumental activities of daily living (IADLS), and Activities of daily living (ADLS) will be measured over the duration of the intervention.
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
Physical Activity Levels
Physical activity levels will be measured using a step activity monitor and actiwatch
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
Gait Speed (m/s)
Changes in gait speed will be calculated over duration of study.
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
Blood Measures
microRNA levels in blood will be measured
Measured: at pre-testing, 1-week post discharge and 4-week post discharge
30 day re-hospitalization
re-hospitalization rates will be collected
Measured: 30 days post-discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2014 (estimated)
- Study startOct 2013
- Primary completionJul 2016
- Study completionDec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 113 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Sponsor type
- University, hospital or other
- Collaborators
- Dairy Research Institute, National Dairy Council
- Responsible party
- Sponsor
- Investigators
- Elena Volpi, MD, PhD, Principal investigator, UTMB
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02203656
- Sponsor's protocol ID
- 13-038
- Other IDs
- 1229
- Acronym
- PACE
- Status last verified
- Dec 2017
- First submitted
- 22 May 2014
- Last updated
- 4 Apr 2019
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No: No. This is a small Phase 1 pre-pilot study. Risk of loss of confidentiality
Publications
Deer RR, Dickinson JM, Fisher SR, Ju H, Volpi E. Identifying effective and feasible interventions to accelerate functional recovery from hospitalization in older adults: A randomized controlled pilot trial. Contemp Clin Trials. 2016 Jul;49:6-14. doi: 10.1016/j.cct.2016.05.001. Epub 2016 May 10.
PubMed 27178766Deer RR, Goodlett SM, Fisher SR, Baillargeon J, Dickinson JM, Raji M, Volpi E. A Randomized Controlled Pilot Trial of Interventions to Improve Functional Recovery After Hospitalization in Older Adults: Feasibility and Adherence. J Gerontol A Biol Sci Med Sci. 2018 Jan 16;73(2):187-193. doi: 10.1093/gerona/glx111.
PubMed 28591764Deer RR, Dickinson JM, Baillargeon J, Fisher SR, Raji M, Volpi E. A Phase I Randomized Clinical Trial of Evidence-Based, Pragmatic Interventions to Improve Functional Recovery After Hospitalization in Geriatric Patients. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1628-1636. doi: 10.1093/gerona/glz084.
PubMed 30906944Arentson-Lantz EJ, Deer RR, Kokonda M, Wen CL, Pecha TA, Carreon SA, Ngyen TM, Volpi E, Nowakowski S. Improvements in sleep quality and fatigue are associated with improvements in functional recovery following hospitalization in older adults. Front Sleep. 2022;1:1011930. doi: 10.3389/frsle.2022.1011930. Epub 2022 Oct 14.
PubMed 37251511
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
- ClinicalTrials.gov ID
- NCT02203656
- Acronym / sponsor ID
- PACE / 13-038
- Conditions
- Aging
- Keywords
- intervention studies, nutrition, exercise, testosterone, patient readmission
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 113 participants (actual)
- Lead sponsor
- The University of Texas Medical Branch, GalvestonUniversity, hospital or other
- Collaborators
- Dairy Research Institute, National Dairy Council
- Study start
- Oct 2013 (actual)
- Primary completion
- Jul 2016 (actual)
- Study completion
- Dec 2017 (actual)
- First posted
- 30 Jul 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test the feasibility of interventions to accelerate recovery of muscle mass and function in older adults following acute hospitalization.
Detailed description
The purpose of this study is to test the feasibility of interventions to accelerate recovery of muscle mass and function in older adults following acute hospitalization
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind (participant)
- Number of arms
- 5
| Arm | Type | Receives |
|---|---|---|
| Placebo Supplement | Placebo comparator | Drug: PlaceboDaily placebo supplement for 30 days after discharge. |
| Nutritional Supplement | Experimental | Dietary Supplement: Nutritional SupplementDaily nutritional supplement for 30 days after discharge. |
| In-home exercise + placebo | Experimental | Drug: Placebo, Behavioral: In-home exercisein-home exercise 3 times a week and daily placebo supplement for 30 days after discharge. |
| In-home exercise + nutrition | Experimental | Dietary Supplement: Nutritional Supplement, Behavioral: In-home exercisein-home exercise 3 times a week and daily nutritional supplement for 30 days after discharge. |
| Testosterone | Experimental | Drug: TestosteroneSingle testosterone injection within 24 hours of hospital discharge. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (8 listed)
- Admitted to the University of Texas Medical Branch (UTMB) ACE unit with an admitting diagnosis of congestive heart failure, respiratory infection, kidney/urinary tract infection, or metabolic disorder; or other condition that will allow a subject to participate in the study after patient review
- Aged 65 years or older
- Self-reported ability (with or without the aid of an assistive device) to walk across a small room two weeks prior to hospitalization
- Lives within 30 miles of UTMB
- Can stand without assistance at the time of pretesting
Key exclusion criteria (14 listed)
- Nursing home resident or hospice patient
- Uncontrolled blood pressure (systolic >150, or diastolic > 100)
- History of stroke with motor disability
- Glomerular filtration rate (GFR) <30 mL/min/1.73m2 or evidence of kidney disease or failure
- Liver disease ( aspartate aminotransferase (AST) /Alanine transaminase (ALT) 2 times above the normal limit, hyperbilirubinemia)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PlaceboAlso: Controlplacebo supplement | Drug | In-home exercise + placebo, Placebo Supplement |
| Nutritional Supplementprotein supplement | Dietary supplement | In-home exercise + nutrition, Nutritional Supplement |
| In-home exerciseIn-home exercise program | Behavioural | In-home exercise + nutrition, In-home exercise + placebo |
| TestosteroneAlso: Testosterone enanthateTestosterone injection | Drug | Testosterone |
Primary outcome
Short Physical Performance Battery- Gait, Balance, Chair Rise changes in functional measure score
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
Changes in SPPB score
7 secondary outcomes
Body Composition
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
Hand grip strength (kg)
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
ADLS, IADLS
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
Physical Activity Levels
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
Gait Speed (m/s)
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
Blood Measures
Time frame: at pre-testing, 1-week post discharge and 4-week post discharge
30 day re-hospitalization
Time frame: 30 days post-discharge
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2019.
- Background: PubMed 27178766Deer RR, Dickinson JM, Fisher SR, Ju H, Volpi E. Identifying effective and feasible interventions to accelerate functional recovery from hospitalization in older adults: A randomized controlled pilot trial. Contemp Clin Trials. 2016 Jul;49:6-14. doi: 10.1016/j.cct.2016.05.001. Epub 2016 May 10.
- Results publication: PubMed 28591764Deer RR, Goodlett SM, Fisher SR, Baillargeon J, Dickinson JM, Raji M, Volpi E. A Randomized Controlled Pilot Trial of Interventions to Improve Functional Recovery After Hospitalization in Older Adults: Feasibility and Adherence. J Gerontol A Biol Sci Med Sci. 2018 Jan 16;73(2):187-193. doi: 10.1093/gerona/glx111.
- Results publication: PubMed 30906944Deer RR, Dickinson JM, Baillargeon J, Fisher SR, Raji M, Volpi E. A Phase I Randomized Clinical Trial of Evidence-Based, Pragmatic Interventions to Improve Functional Recovery After Hospitalization in Geriatric Patients. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1628-1636. doi: 10.1093/gerona/glz084.
- Derived from this study: PubMed 37251511Arentson-Lantz EJ, Deer RR, Kokonda M, Wen CL, Pecha TA, Carreon SA, Ngyen TM, Volpi E, Nowakowski S. Improvements in sleep quality and fatigue are associated with improvements in functional recovery following hospitalization in older adults. Front Sleep. 2022;1:1011930. doi: 10.3389/frsle.2022.1011930. Epub 2022 Oct 14.
- Individual participant dataSharing planned: No. No. This is a small Phase 1 pre-pilot study. Risk of loss of confidentiality
Related trials for Aging
RecruitingObservational study
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
RecruitingPhase 1/2
Precision Microbiota Interventions for Senoreduction Trial
HIV Infections, Alcohol Drinking
Recruiting
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
Ageism, Loneliness
Not yet recruiting
Effect of HMB Supplementation and Vivifrail Exercise on Body Composition, Handgrip Strength and Physical Performance in Women Over 60 Years of Age
Aging, Muscle Strength
Not yet recruiting
Cerebello-Cortical Connectivity and Balance Adaptation in Younger and Older Adults
Aging, Postural Balance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elena Volpi, MD, PhD principal investigator
UTMB
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing Nutritional Supplement, In-home exercise and Testosterone in people with Aging, run by The University of Texas Medical Branch, Galveston at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Short Physical Performance Battery- Gait, Balance, Chair Rise changes in functional measure score (time frame: at pre-testing, 1-week post discharge and 4-week post discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02203656, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2019; AzTrials last refreshed its copy on 30 Oct 2026.